Atlas Trials

Efficacy of 300 mg Ibuprofen Prolonged-Release Tablets for the Treatment of Pain After Surgical Removal of Impacted Third Molars

Clinical trial NCT03785756 · COMPLETED

Trial details

NCT number
NCT03785756
Sponsor
Reckitt Benckiser Healthcare (UK) Limited
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Pain
Start date
2019-04-29
Primary completion
2020-02-20
Enrollment
280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.